These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31925635)

  • 1. Honey as the Potential Natural Source of Cholinesterase Inhibitors in Alzheimer's Disease.
    Baranowska-Wójcik E; Szwajgier D; Winiarska-Mieczan A
    Plant Foods Hum Nutr; 2020 Mar; 75(1):30-32. PubMed ID: 31925635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honeys as Possible Sources of Cholinesterase Inhibitors.
    Szwajgier D; Baranowska-Wójcik E; Winiarska-Mieczan A; Gajowniczek-Ałasa D
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BChE inhibitors from marine organisms - A review.
    Lins Alves LK; Cechinel Filho V; de Souza RLR; Furtado-Alle L
    Chem Biol Interact; 2022 Nov; 367():110136. PubMed ID: 36096160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
    Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
    Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Design of Inhibitors of Alzheimer's Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of β-amino di-Carbonyl Derivatives.
    Hadda TB; Rauf A; Zgou H; Senol FS; Orhan IE; Mabkhot YN; Althagafi II; Farghaly TA; Alterary S
    Mini Rev Med Chem; 2019; 19(8):688-705. PubMed ID: 30387392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease.
    Szymański P; Janik A; Zurek E; Mikiciuk-Olasik E
    Pharmazie; 2011 Jun; 66(6):399-403. PubMed ID: 21699076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regardless of the Brewing Conditions, Various Types of Tea are a Source of Acetylcholinesterase Inhibitors.
    Baranowska-Wójcik E; Szwajgier D; Winiarska-Mieczan A
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32155927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
    Darvesh S
    Curr Alzheimer Res; 2016; 13(10):1173-7. PubMed ID: 27040140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
    Parnetti L; Chiasserini D; Andreasson U; Ohlson M; Hüls C; Zetterberg H; Minthon L; Wallin AK; Andreasen N; Talesa VN; Blennow K
    Acta Neurol Scand; 2011 Aug; 124(2):122-9. PubMed ID: 20880294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetamide Derivatives of Chromen-2-ones as Potent Cholinesterase Inhibitors.
    Prasad S; Kumar B; Kumar S; Chand K; Kamble SS; Gautam HK; Sharma SK
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28699213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
    Macdonald IR; Rockwood K; Martin E; Darvesh S
    J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
    Mushtaq G; Greig NH; Khan JA; Kamal MA
    CNS Neurol Disord Drug Targets; 2014; 13(8):1432-9. PubMed ID: 25345511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.